Rare diseases
Investigational molecules
Locations
1 Marina Park Drive Floor 12th, 02210-1832, United States
Clinical research in renal cell carcinoma centers on treatment strategies for disease that has progressed after prior immune checkpoint inhibitor-based therapy. The sponsor’s studies in this area examine combinations involving tivozanib and nivolumab, with attention to progression-free survival and overall survival in advanced kidney cancer.
The focus includes patients with previously treated metastatic renal cell carcinoma and the evaluation of combination therapy in later-line disease.
Aveo Pharmaceuticals Inc. runs clinical trials in conditions such as Squamous cell carcinoma of head and neck, Renal cell carcinoma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
